Biological consequences of oxidation in atherosclerosis and other pathologies. Lipoprotein oxidation in brain arteries

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 7, Issue 3, 1997, Pages 237-247

  Palinski, W ^a,b   Horkko S ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Autoantibodies; Brain; Immune responses; Lipoprotein oxidation

Indexed keywords

EID: 0000759308     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Consensus Conference (1985) Lowering blood cholesterol to prevent coronary heart disease. JAMA 253: 2080-2090
2. European Atherosclerosis Society Study Group (1987) Strategies for the prevention of coronary heart disease. Eur Heart J 8: 77-88
3. Steinberg D (1989) The cholesterol controversy is over. Why did it take so long? Circulation 80: 1070-1078
4. Pederson TR, Kjekhus J, Berg K, et al. (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389
5. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol. Modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924
6. Witztum JL (1994) The oxidation hypothesis of atherosclerosis. Lancet 344: 793-795
7. Palinski W, Witztum JL (1995) Oxidative stress and diabetes mellitus. In: Born GVR, Schwartz CD (eds) New horizons in diabetes mellitus and coronary heart disease. Current Science, London, pp 111-123
8. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ (1995) Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91: 2488-2496
9. Haberland ME, Fong D, Cheng L (1988) Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241: 215-218
10. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SA, Butler S, Parthasarathy S, Carew TE, Steinberg D, Witztum JL (1989) Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 86: 1372-1376
11. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84: 1086-1095
12. Boyd HC, Gown AM, Wolfbauer G, Chait A (1989) Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe Heritable Hyperlipidemic rabbit. Am J Pathol 135: 815-826
13. Rosenfeld ME, Palinski W, Ylä-Herttuala S, Butler S, Witztum JL (1990) Distribution of oxidation-specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 10: 336-349
14. Jürgens G, Chen Q, Esterbauer H, Mair S, Ledinski G, Dinges HP (1993) Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). ArteriosclerThromb 13: 1689-1699
15. Palinski W, Ord V, Plump AS, Breslow JL, Steinberg D, Witztum JL (1994) ApoE deficient mice are a model of lipoprotein oxidation in atherogenesis: Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 14: 605-616
16. Palinski W, Tangirala RK, Miller E, Young SG, Witztum JL (1995) Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol 15: 1569-1576
17. Carew TE, Schwenke DC, Steinberg D (1987) Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks slowing the progression of atherosclerosis in the WHHL rabbit. Proc Natl Acad Sci USA 84: 7725-7729
18. Björkhem I, Henriksson-Freyschuss A, Breuer O, Diczfalusy U, Berglund L, Henriksson P (1991) The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler Thromb 11: 15-22
19. Sparrow CP, Doebber TW, Olszewski J, Wu MS, Ventre J, Stevens KA, Chao YS (1992) Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N"-diphenyl-phenylenediamine. J Clin Invest 89: 1885-1891
20. Sasahara M, Raines EW, Chait A, Carew TE, Steinberg D, Wahl PW, Ross R (1994) Inhibition of hypercholesterolemia-induced atherosclerosis in Macaca Nemestrina by probucol: I. Intimal lesion area correlates inversely with resistance of lipoproteins to oxidation. J Clin Invest 94: 155-164
21. Tangirala RK, Casanada F, Witztum JL, Steinberg D, Palinski W (1995) Effect of the antioxidant N.N'-diphenyl 1,4-phenylenediamine (DPPD) on atherogenesis in apoE-deficient mice. Arterioscler Thromb Vasc Biol 15: 1625-1630
22. McGill HC, Arias-Stella J, Carbonell LM, et al. (1968) General findings of the International Atherosclerosis Project. Lab Invest 18: 498-512
23. Gorelick PB (1993) Distribution of atherosclerotic cerebrovascular lesions. Effects of age, race, and sex. Stroke 24(12 Suppl): 116-121
24. Quinn MT, Parthasarathy S, Fong LG, Steinberg D (1987) Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 84: 2995-2998
25. Quinn MT, Parthasarathy S, Steinberg D (1988) Lysophosphatidylcholine A new chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA 85: 2805-2809
26. Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76: 333-337
27. Kodama T, Freeman M, Rohrer L, Zabrecky T, Matsudaira P, Krieger M (1990) Type I macrophage scavanger receptor contains alpha-helical and collagen-like coiled coils. Nature 343: 531-535
28. Ramprasad M, Fischer W, Witztum JL, Sambrano G, Quehenberger O, Steinberg D (1995) The 94-96 kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA 92: 9580-9584
29. Hessler JR, Robertson AL Jr., Chisolm GM (1979) LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 32: 213-229
30. Palinski W, Ylä-Herttuala S, Rosenfeld ME, Butler S, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL (1990) Antisera and monoclonal antibodies specific for epitopes generated during the oxidative modification of low density lipoprotein. Arteriosclerosis 10: 325-335
31. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD (1990) Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoproteins. Nature 344: 160-162
32. Radomski MW, Moncada S (1993) Regulation of vascular homeostasis by nitric oxide. Thromb Haemost 70: 36-41
33. Aviram M (1989) Modified forms of low density lipoprotein affect platelet aggregation in vitro. Thromb Res 53: 561-567
34. Fei H, Berliner JA, Parhami, Drake TA (1993) Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler Thromb 13: 1711-1717
35. Liao F, Andalibi A, Qiao JH, Allayee H, Fogelman AM, Lusis AJ (1994) Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest 94: 877-884
36. Fruebis J, Carew TE, Palinski W (1995) Effect of vitamin E on atherogenesis in LDL receptor-deficient rabbits. Atherosclerosis 117: 217-224
37. Fruebis J, Steinberg D, Dresel HA, Carew TE (1994) A comparison of the antiatherogenic effects of probucol and of a structural analog of probucol in LDL-receptor-deficient rabbits. J Clin Invest 94: 392-398
38. Clinton SK, Libby P (1992) Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med 116: 1292-1300
39. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM (1990) Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87: 5134-5138
40. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ (1990) Induction of endothelial cell expression of granulocyte and macrophage colony stimulating factors by modified low density lipoproteins. Nature 334: 254-257
41. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ (1993) Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91: 2572-2579
42. Kume N, Cybulski MI, Gimbrone MA (1992) Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90: 1138-1144
43. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. Embo J 12: 2005-2015
44. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM (1993) Vascular cell adhesion molecule-1 (VCAM-I) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92: 1866-1874
45. Khan BV, Parthasarathy S, Alexander RW, Medford RM (1995) Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95: 1262-1270
46. Faruqi R, de la Motte C, DiCorleto PE (1994) Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells. J Clin Invest 94: 592-600
47. Fruebis J, Gonzales V, Silvestre M, Palinski W (1997) Effect of probucol treatment on gene expression of VCAM-1, MCP-1 and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis. Arterioscler Thromb Vasc Biol - in press
48. Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Rad Biol Chem 11: 81-128
49. Steinbrecher UP (1987) Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem 262: 3603-3608
50. Witztum JL, Steinbrecher UP, Fisher M, Kesäniemi A (1983) Nonenzymatic glucosylation of homologous LDL and albumin render them immunogenic in the guinea-pig. Proc Natl Acad Sci USA 80: 2757-2761
51. Rosenfeld ME, Khoo JC, Miller E, Parthasarathy S, Palinski W, Witztum JL (1991) Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of LDL, and contain oxidation specific lipid-protein adducts. J Clin Invest 87: 90-99
52. Parums DV, Brown DL, Mitchinson MJ (1990) Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis Arch Pathol Lab Med 114: 383-387
53. Orekhov AN, Tertov VV, Kabakov AE, Adamova IYu, Pokrovsky SN, Smirnov VN (1991) Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. Arterioscler Thromb 11: 316-326
54. Palinski W, Hörkkö S, Miller E, Steinbrecher UP, Powell HC, Curtiss LK, Witztum JL (1996) Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apo E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 98: 800-814
55. Hörkkö S, Miller E, Dudl E, Reaven PD, Zvaifler NJ, Terkeltaub R, Pierangeli SS, Curtiss LK, Branch WD, Palinski W, Witztum JL (1996) Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids: Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low-density lipoprotein. J Clin Invest 98: 815-825
56. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL (1992) Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339: 883-887
57. Maggi E, Finardi G, Poli M, Bollati P, Filipponi M, Stefano PL, Paolini G, Grossi A, Clot P, Albano E, Bellomo G (1993) Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk. Coron Artery Dis 4: 1119-1122
58. Virella G, Virella I, Leman RB, Pryor MB, Lopes-Virella MF (1993) Antioxidized low density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Intl J Clin Lab Res 23: 95-101
59. Branch DW, Mitchell MD, Miller E, Palinski W, Witztum JL (1994) Pre-eclampsia and serum antibodies to oxidized low density lipoprotein. Lancet 343: 645-646
60. Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, Finardi G, Bellomo G (1994) LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. Arteriosder Thromb 14: 1892-1899
61. Puurunen M, Mänttäri M, Manninen V, Tenkanen L, Alfthan G, Ehnholm C, Vaarala O, Aho K, Palosuo T (1994) Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med 154: 2605-2609
62. Bellomo G, Maggi E, Poli M, Agosta FG, Bollati P, Finardi G (1995) Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes 44: 60-66
63. Bergmark C, Wu R, de Faire U, Lefvert AK, Swedenborg J (1995) Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol 15: 441-445
64. Palinski W, Tangirala R, Miller E, Young SG, Witztum JL (1995) Increased autoantibody titers against epitopes of oxidized low density lipoprotein in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol 15: 1569-1576
65. Libby P, Hansson GK (1991) Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions. Lab Invest 64: 5-15
66. Khoo JC, Miller E, Pio F, Steinberg D, Witztum JL (1992) Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. Arterioscler Thromb 12: 1258-1266
67. Lopes-Virella MF, Griffith RL, Shunk KA, Virella GT (1991) Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies. Arterioscler Thromb 11: 1356-1367
68. Kishikawa H, Shimokama T, Watanabe T (1993) Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis. Virchows Arch [A] 423: 433-442
69. Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson GK (1985) Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest 76: 125-131
70. Xu Q, Oberhuber G, Gruschwitz M, Wick G (1990) Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol 56: 344-359
71. Stemme S, Holm J, Hansson GK (1992) T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 12: 206-211
72. Vlaicu R, Niculescu F, Rus HG, Cristea A (1985) Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. Atherosclerosis 7: 163-177
73. Ylä-Herttuala S, Palinski W, Butler S, Picard S, Steinberg D, Witztum JL (1994) Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized low density lipoprotein. Arterioscler Thromb 14: 32-40
74. Xu Q, Dietrich H, Steiner HJ, Gown AM, Mikuz G, Kaufmann SHE, Wick G (1992) Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 12: 789-799
75. Palinski W, Miller E, Witztum JL (1995) Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA 92: 821-825
76. Ameli S, Hultgårdth-Nilsson A, Regnström J, Calara F, Yano J, Cerek B, Shah PK, Nilsson J (1996) Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 16: 1074-1079
77. Hansson GK, Holm J, Holm S, Fotev Z, Hedric HJ, Fingerle J (1991) T lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci USA 88: 10530-10534
78. Roselaar SE, Schonfeld G, Daugherty A (1995) Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J Clin Invest 96: 1389-1394
79. Fyfe AI, Qiao JH, Lusis AJ (1994) Immune deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J Clin Invest 94: 2516-2520
80. Ohara Y, Peterson TE, Harrison DG (1993) Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91: 2546-2551
81. Sambrano G, Steinberg D (1995) Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: Role of membrane phosphatidylserine. Proc Natl Acad Sci USA 92: 1396-1400
82. Newcombe J, Li H, Cuzner ML (1994) Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol Appl Neurobiol 20: 152-162
83. Neale TJ, Ojha PP, Exner M, Poczewski H, Rüger B, Witztum JL, Davis P, Kerjaschki D (1994) Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J Clin Invest 94: 1577-1584
84. Yan SD, Chen X, Schmidt AM, Brett J, Godman G, Zou YS, Scott CW, Caputo C, Frappier T, Smith MA, Perry G, Yen SH, Stern D (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 91: 7787-7791
85. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 88: 10540-10543
86. Mark RJ, Blanc EM, Mattson MP (1996) Amyloid beta-peptide and oxidative injury in Alzheimer's Disease. Mol Neurobiol 12: 211-224
87. Vaarala O, Alfthan G, Jauhiainen M, Leirisalo-Repo M, Aho K, Palosuo T (1993) Cross-reaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 341: 923-925
88. Savolainen A, von Essen R, Leikola J, Alfthan G, Vaarala O, Palosuo T, Aho K (1995) Antibodies against oxidised low-density lipoprotein in juvenile chronic arthritis. Scand J Rheumatol 24: 209-211
89. Amara A, Constans J, Chaugier C, Sebban A, Dubourg L, Peuchant E, Pellegrin JL, Leng B, Conri C, Geffard M (1995) Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides. Clin Exp Immunol 101: 233-238
90. Witztum JL, Palinski W (1996) Autoimmunity to oxidized lipoproteins. In: Hansson GK, Libby P (eds) Immune functions of the vessel wall. Harwood Academic Publishers, Amsterdam pp 159-172